Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Manganese | 26 | 2024 | 87 | 9.890 |
Why?
|
Astrocytes | 31 | 2023 | 255 | 9.570 |
Why?
|
Excitatory Amino Acid Transporter 2 | 13 | 2021 | 38 | 6.950 |
Why?
|
Manganese Poisoning | 11 | 2023 | 22 | 5.020 |
Why?
|
YY1 Transcription Factor | 7 | 2022 | 18 | 4.640 |
Why?
|
Excitatory Amino Acid Transporter 1 | 7 | 2020 | 16 | 3.670 |
Why?
|
Up-Regulation | 9 | 2024 | 513 | 3.120 |
Why?
|
Amino Acid Transport System X-AG | 5 | 2017 | 11 | 2.120 |
Why?
|
Repressor Proteins | 4 | 2022 | 249 | 2.050 |
Why?
|
Parkinson Disease | 6 | 2023 | 178 | 1.900 |
Why?
|
Brain | 9 | 2022 | 1346 | 1.880 |
Why?
|
Estradiol | 3 | 2024 | 262 | 1.720 |
Why?
|
Transforming Growth Factor alpha | 5 | 2017 | 22 | 1.690 |
Why?
|
Microglia | 4 | 2024 | 166 | 1.680 |
Why?
|
Animals | 46 | 2024 | 15081 | 1.470 |
Why?
|
Dopamine | 6 | 2023 | 245 | 1.470 |
Why?
|
Gene Expression Regulation | 7 | 2021 | 1015 | 1.360 |
Why?
|
Oxidative Stress | 10 | 2024 | 938 | 1.330 |
Why?
|
Valproic Acid | 2 | 2018 | 16 | 1.230 |
Why?
|
Transcription, Genetic | 5 | 2021 | 578 | 1.210 |
Why?
|
NF-kappa B | 7 | 2017 | 339 | 1.210 |
Why?
|
Cells, Cultured | 17 | 2021 | 1518 | 1.190 |
Why?
|
Neuroprotective Agents | 5 | 2024 | 245 | 1.170 |
Why?
|
Tamoxifen | 3 | 2017 | 65 | 1.140 |
Why?
|
Nervous System Diseases | 2 | 2019 | 71 | 1.100 |
Why?
|
Neurotoxins | 3 | 2021 | 57 | 1.100 |
Why?
|
Neurotoxicity Syndromes | 3 | 2021 | 35 | 1.000 |
Why?
|
Tyrosine 3-Monooxygenase | 3 | 2020 | 78 | 0.950 |
Why?
|
Sp1 Transcription Factor | 1 | 2024 | 48 | 0.950 |
Why?
|
Yin-Yang | 1 | 2022 | 2 | 0.880 |
Why?
|
I-kappa B Kinase | 2 | 2021 | 44 | 0.870 |
Why?
|
Mice | 12 | 2024 | 5913 | 0.870 |
Why?
|
Parkinsonian Disorders | 1 | 2023 | 37 | 0.870 |
Why?
|
Rats | 20 | 2016 | 3483 | 0.840 |
Why?
|
alpha-Synuclein | 2 | 2020 | 52 | 0.820 |
Why?
|
Reactive Oxygen Species | 3 | 2021 | 461 | 0.810 |
Why?
|
Cation Transport Proteins | 2 | 2021 | 34 | 0.800 |
Why?
|
Substantia Nigra | 2 | 2020 | 44 | 0.800 |
Why?
|
Estrogens | 2 | 2014 | 202 | 0.790 |
Why?
|
Rats, Sprague-Dawley | 16 | 2016 | 1618 | 0.780 |
Why?
|
Inflammation | 3 | 2022 | 618 | 0.760 |
Why?
|
Lysophosphatidylcholines | 3 | 2005 | 22 | 0.750 |
Why?
|
Motor Activity | 3 | 2017 | 418 | 0.740 |
Why?
|
Receptors, G-Protein-Coupled | 4 | 2014 | 86 | 0.720 |
Why?
|
Protein Processing, Post-Translational | 2 | 2018 | 173 | 0.710 |
Why?
|
Selective Estrogen Receptor Modulators | 3 | 2014 | 32 | 0.690 |
Why?
|
Tumor Necrosis Factor-alpha | 5 | 2024 | 356 | 0.670 |
Why?
|
Apoptosis | 4 | 2022 | 1398 | 0.650 |
Why?
|
Cell Line | 6 | 2024 | 1354 | 0.650 |
Why?
|
Promoter Regions, Genetic | 6 | 2021 | 515 | 0.650 |
Why?
|
Epigenesis, Genetic | 3 | 2015 | 219 | 0.640 |
Why?
|
Signal Transduction | 9 | 2017 | 1908 | 0.620 |
Why?
|
Humans | 27 | 2024 | 37093 | 0.620 |
Why?
|
Caprylates | 1 | 2017 | 11 | 0.600 |
Why?
|
Butyric Acid | 1 | 2017 | 18 | 0.600 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 2 | 2013 | 54 | 0.550 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2020 | 77 | 0.540 |
Why?
|
Glutamic Acid | 5 | 2021 | 128 | 0.530 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 98 | 0.440 |
Why?
|
Histone Deacetylases | 3 | 2020 | 56 | 0.420 |
Why?
|
Oncogene Proteins | 1 | 2011 | 21 | 0.410 |
Why?
|
Prostaglandin D2 | 1 | 2011 | 27 | 0.400 |
Why?
|
Mutation | 3 | 2023 | 1095 | 0.400 |
Why?
|
Chlorides | 4 | 2020 | 56 | 0.400 |
Why?
|
Lewy Bodies | 2 | 2023 | 30 | 0.390 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2011 | 187 | 0.370 |
Why?
|
S-Adenosylmethionine | 3 | 2005 | 38 | 0.360 |
Why?
|
Base Sequence | 3 | 2020 | 997 | 0.360 |
Why?
|
Protein Binding | 4 | 2020 | 972 | 0.330 |
Why?
|
Phosphatidylethanolamine N-Methyltransferase | 2 | 2005 | 6 | 0.330 |
Why?
|
Excitatory Amino Acid Antagonists | 2 | 2006 | 99 | 0.330 |
Why?
|
Locomotion | 2 | 2020 | 97 | 0.320 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2020 | 152 | 0.310 |
Why?
|
RNA, Messenger | 3 | 2020 | 1207 | 0.300 |
Why?
|
Phospholipids | 2 | 2005 | 70 | 0.300 |
Why?
|
Dopamine Antagonists | 2 | 2004 | 44 | 0.300 |
Why?
|
Phosphorylation | 4 | 2021 | 928 | 0.300 |
Why?
|
Mice, Inbred C57BL | 4 | 2018 | 1609 | 0.280 |
Why?
|
Phencyclidine | 1 | 2006 | 19 | 0.280 |
Why?
|
Neurotransmitter Agents | 2 | 2020 | 63 | 0.280 |
Why?
|
Glutamine | 4 | 2019 | 40 | 0.270 |
Why?
|
Transcriptional Activation | 2 | 2020 | 172 | 0.270 |
Why?
|
MPTP Poisoning | 1 | 2005 | 11 | 0.260 |
Why?
|
Manganese Compounds | 4 | 2020 | 16 | 0.260 |
Why?
|
Homocysteine | 1 | 2005 | 19 | 0.260 |
Why?
|
Estrogen Receptor alpha | 2 | 2017 | 111 | 0.260 |
Why?
|
Neurons | 4 | 2019 | 1175 | 0.260 |
Why?
|
Membrane Transport Proteins | 2 | 2015 | 95 | 0.260 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 137 | 0.260 |
Why?
|
Nerve Degeneration | 3 | 2021 | 107 | 0.250 |
Why?
|
Tyrosine | 1 | 2005 | 118 | 0.250 |
Why?
|
Mammals | 2 | 2022 | 105 | 0.250 |
Why?
|
Response Elements | 2 | 2015 | 56 | 0.240 |
Why?
|
Transcription Factors | 3 | 2020 | 681 | 0.240 |
Why?
|
Neurodegenerative Diseases | 3 | 2021 | 131 | 0.240 |
Why?
|
Cerebral Cortex | 3 | 2017 | 290 | 0.240 |
Why?
|
Receptors, Dopamine | 1 | 2004 | 25 | 0.230 |
Why?
|
Carrier Proteins | 2 | 2020 | 305 | 0.230 |
Why?
|
Glutathione | 2 | 2017 | 179 | 0.230 |
Why?
|
Metals, Heavy | 1 | 2024 | 60 | 0.230 |
Why?
|
Behavior, Animal | 1 | 2005 | 314 | 0.220 |
Why?
|
Cell Differentiation | 1 | 2006 | 587 | 0.210 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 211 | 0.210 |
Why?
|
Blotting, Western | 5 | 2012 | 859 | 0.210 |
Why?
|
Autophagy | 1 | 2023 | 116 | 0.210 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2021 | 49 | 0.200 |
Why?
|
Gene Deletion | 1 | 2022 | 166 | 0.200 |
Why?
|
RNA, Small Interfering | 3 | 2012 | 409 | 0.200 |
Why?
|
Serine | 1 | 2021 | 75 | 0.200 |
Why?
|
Nerve Tissue Proteins | 1 | 2004 | 360 | 0.200 |
Why?
|
Retina | 1 | 2024 | 280 | 0.200 |
Why?
|
Male | 7 | 2020 | 20025 | 0.200 |
Why?
|
Parenteral Nutrition | 1 | 2021 | 13 | 0.190 |
Why?
|
Cell Survival | 3 | 2017 | 864 | 0.190 |
Why?
|
Transferrin | 1 | 2020 | 40 | 0.190 |
Why?
|
Methylation | 3 | 2005 | 113 | 0.190 |
Why?
|
Calcium Channels | 1 | 2020 | 76 | 0.180 |
Why?
|
Brain Chemistry | 3 | 2005 | 140 | 0.180 |
Why?
|
CREB-Binding Protein | 1 | 2020 | 13 | 0.180 |
Why?
|
Models, Biological | 2 | 2014 | 677 | 0.180 |
Why?
|
Heme Oxygenase-1 | 1 | 2020 | 51 | 0.180 |
Why?
|
Interleukin-1beta | 1 | 2020 | 70 | 0.170 |
Why?
|
Drug Interactions | 2 | 2012 | 141 | 0.170 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2017 | 93 | 0.170 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 2006 | 421 | 0.170 |
Why?
|
Amino Acid Sequence | 1 | 2021 | 1180 | 0.160 |
Why?
|
Down-Regulation | 1 | 2020 | 435 | 0.160 |
Why?
|
Anticonvulsants | 1 | 2018 | 34 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2017 | 269 | 0.160 |
Why?
|
Malondialdehyde | 1 | 2017 | 41 | 0.150 |
Why?
|
Ovariectomy | 1 | 2017 | 105 | 0.150 |
Why?
|
bcl-2-Associated X Protein | 1 | 2017 | 77 | 0.150 |
Why?
|
Rotarod Performance Test | 1 | 2017 | 14 | 0.150 |
Why?
|
Mice, Knockout | 1 | 2020 | 933 | 0.150 |
Why?
|
Catalase | 1 | 2017 | 109 | 0.150 |
Why?
|
Cerebellum | 1 | 2017 | 73 | 0.150 |
Why?
|
Immunohistochemistry | 2 | 2012 | 893 | 0.140 |
Why?
|
Mice, Transgenic | 1 | 2018 | 617 | 0.140 |
Why?
|
Analysis of Variance | 3 | 2011 | 550 | 0.130 |
Why?
|
Quinazolines | 1 | 2016 | 33 | 0.130 |
Why?
|
PC12 Cells | 2 | 2006 | 93 | 0.130 |
Why?
|
Tritium | 2 | 2006 | 51 | 0.130 |
Why?
|
Dizocilpine Maleate | 2 | 2006 | 48 | 0.130 |
Why?
|
Protein Transport | 2 | 2015 | 302 | 0.130 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2015 | 37 | 0.130 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2012 | 114 | 0.130 |
Why?
|
Cytoprotection | 2 | 2011 | 36 | 0.130 |
Why?
|
Cytokines | 1 | 2019 | 602 | 0.130 |
Why?
|
Gene Expression | 1 | 2018 | 674 | 0.130 |
Why?
|
Injections, Intraventricular | 2 | 2005 | 64 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2011 | 1039 | 0.120 |
Why?
|
Estrogen Receptor beta | 1 | 2014 | 40 | 0.120 |
Why?
|
Protein Kinase C | 2 | 2012 | 120 | 0.120 |
Why?
|
Alzheimer Disease | 2 | 2019 | 905 | 0.120 |
Why?
|
Transcription Factor RelA | 1 | 2014 | 40 | 0.120 |
Why?
|
Cell Extracts | 1 | 2013 | 16 | 0.120 |
Why?
|
Homeostasis | 1 | 2015 | 188 | 0.120 |
Why?
|
Protein Biosynthesis | 1 | 2014 | 133 | 0.120 |
Why?
|
Forkhead Transcription Factors | 1 | 2014 | 76 | 0.120 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 73 | 0.120 |
Why?
|
Animals, Newborn | 5 | 2014 | 343 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2014 | 136 | 0.110 |
Why?
|
src-Family Kinases | 1 | 2013 | 46 | 0.110 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2013 | 76 | 0.110 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 173 | 0.110 |
Why?
|
Amino Acid Transport System ASC | 2 | 2011 | 3 | 0.110 |
Why?
|
Amino Acid Transport Systems, Neutral | 2 | 2011 | 4 | 0.110 |
Why?
|
Kinetics | 2 | 2005 | 708 | 0.110 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 169 | 0.110 |
Why?
|
Receptors, Estrogen | 1 | 2013 | 156 | 0.110 |
Why?
|
Chemokines | 1 | 2012 | 97 | 0.100 |
Why?
|
Protein Kinases | 1 | 2012 | 100 | 0.100 |
Why?
|
Morpholines | 1 | 2011 | 69 | 0.100 |
Why?
|
DNA Primers | 1 | 2012 | 286 | 0.100 |
Why?
|
Binding Sites | 1 | 2013 | 651 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2012 | 123 | 0.100 |
Why?
|
Chromones | 1 | 2011 | 54 | 0.100 |
Why?
|
Gene Silencing | 1 | 2012 | 151 | 0.100 |
Why?
|
Mercury Poisoning, Nervous System | 1 | 2011 | 2 | 0.100 |
Why?
|
Methylmercury Compounds | 1 | 2011 | 4 | 0.100 |
Why?
|
Organoselenium Compounds | 1 | 2011 | 10 | 0.100 |
Why?
|
Azoles | 1 | 2011 | 14 | 0.100 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2010 | 5 | 0.100 |
Why?
|
Dipeptides | 1 | 2010 | 32 | 0.090 |
Why?
|
Female | 3 | 2020 | 20969 | 0.090 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 448 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2012 | 213 | 0.090 |
Why?
|
Ovarian Neoplasms | 1 | 2012 | 312 | 0.080 |
Why?
|
Environmental Pollutants | 1 | 2011 | 179 | 0.080 |
Why?
|
Antioxidants | 1 | 2011 | 416 | 0.070 |
Why?
|
Biogenic Amines | 1 | 2006 | 11 | 0.070 |
Why?
|
Nerve Growth Factor | 1 | 2006 | 30 | 0.070 |
Why?
|
N-Methylaspartate | 1 | 2006 | 57 | 0.070 |
Why?
|
Neurites | 1 | 2006 | 39 | 0.070 |
Why?
|
S-Adenosylhomocysteine | 1 | 2005 | 9 | 0.070 |
Why?
|
Phosphatidylethanolamines | 1 | 2005 | 27 | 0.070 |
Why?
|
Catheterization | 1 | 2005 | 24 | 0.070 |
Why?
|
Neostriatum | 1 | 2005 | 26 | 0.060 |
Why?
|
Phosphatidylcholines | 1 | 2005 | 47 | 0.060 |
Why?
|
Hypokinesia | 1 | 2005 | 3 | 0.060 |
Why?
|
Quinacrine | 1 | 2005 | 5 | 0.060 |
Why?
|
1-Methyl-4-phenylpyridinium | 1 | 2005 | 30 | 0.060 |
Why?
|
Chromatography, Thin Layer | 1 | 2005 | 37 | 0.060 |
Why?
|
Adenosine | 1 | 2005 | 59 | 0.060 |
Why?
|
Gliosis | 1 | 2004 | 24 | 0.060 |
Why?
|
Ibuprofen | 1 | 2004 | 32 | 0.060 |
Why?
|
Apigenin | 1 | 2004 | 13 | 0.060 |
Why?
|
Pyridinium Compounds | 1 | 2005 | 27 | 0.060 |
Why?
|
Mazindol | 1 | 2004 | 4 | 0.060 |
Why?
|
Methyltransferases | 1 | 2005 | 58 | 0.060 |
Why?
|
Serotonin | 1 | 2005 | 123 | 0.060 |
Why?
|
Radioligand Assay | 1 | 2004 | 66 | 0.060 |
Why?
|
Binding, Competitive | 1 | 2004 | 111 | 0.060 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2004 | 50 | 0.060 |
Why?
|
Macular Degeneration | 1 | 2024 | 29 | 0.060 |
Why?
|
Receptors, Dopamine D1 | 1 | 2004 | 40 | 0.060 |
Why?
|
Receptors, Dopamine D2 | 1 | 2004 | 73 | 0.060 |
Why?
|
Benzazepines | 1 | 2004 | 32 | 0.060 |
Why?
|
Tissue Distribution | 1 | 2004 | 207 | 0.060 |
Why?
|
Benzamides | 1 | 2004 | 78 | 0.060 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2004 | 77 | 0.060 |
Why?
|
Corpus Striatum | 1 | 2004 | 104 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2004 | 149 | 0.050 |
Why?
|
Ubiquitination | 2 | 2012 | 61 | 0.050 |
Why?
|
Cell Membrane | 1 | 2004 | 381 | 0.050 |
Why?
|
Liver | 1 | 2005 | 479 | 0.050 |
Why?
|
Immunoprecipitation | 2 | 2012 | 131 | 0.050 |
Why?
|
Metabolome | 1 | 2021 | 53 | 0.050 |
Why?
|
Cell Nucleus | 2 | 2014 | 366 | 0.050 |
Why?
|
Immunity | 1 | 2021 | 53 | 0.050 |
Why?
|
Trace Elements | 1 | 2021 | 30 | 0.050 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2011 | 11 | 0.050 |
Why?
|
Risk | 1 | 2021 | 267 | 0.050 |
Why?
|
Synaptic Transmission | 1 | 2021 | 146 | 0.050 |
Why?
|
Time Factors | 2 | 2014 | 1742 | 0.040 |
Why?
|
Thiazolidines | 1 | 2014 | 5 | 0.030 |
Why?
|
Pyrrolidonecarboxylic Acid | 1 | 2014 | 7 | 0.030 |
Why?
|
Enzyme Induction | 1 | 2014 | 53 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2014 | 59 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 2014 | 155 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2014 | 444 | 0.030 |
Why?
|
Child | 1 | 2021 | 3131 | 0.030 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2012 | 8 | 0.030 |
Why?
|
Protein Kinase C-delta | 1 | 2012 | 18 | 0.030 |
Why?
|
Protein Kinase C-alpha | 1 | 2012 | 10 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 40 | 0.030 |
Why?
|
Indicators and Reagents | 1 | 2012 | 58 | 0.030 |
Why?
|
Translocation, Genetic | 1 | 2012 | 42 | 0.030 |
Why?
|
Cytosol | 1 | 2012 | 93 | 0.030 |
Why?
|
Caspases | 1 | 2012 | 147 | 0.030 |
Why?
|
Lysosomes | 1 | 2012 | 91 | 0.030 |
Why?
|
Biotinylation | 1 | 2011 | 11 | 0.030 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2011 | 10 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2012 | 502 | 0.020 |
Why?
|
Endocytosis | 1 | 2012 | 113 | 0.020 |
Why?
|
Isoindoles | 1 | 2011 | 18 | 0.020 |
Why?
|
Ubiquitin | 1 | 2011 | 78 | 0.020 |
Why?
|
Hepatic Encephalopathy | 1 | 2010 | 11 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2011 | 84 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2011 | 75 | 0.020 |
Why?
|
Caspase 3 | 1 | 2011 | 207 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 252 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2011 | 517 | 0.020 |
Why?
|
Mitochondria | 1 | 2011 | 487 | 0.020 |
Why?
|
Adult | 1 | 2021 | 11712 | 0.020 |
Why?
|
Annexin A5 | 1 | 2004 | 26 | 0.020 |
Why?
|
Propidium | 1 | 2004 | 19 | 0.020 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2004 | 22 | 0.020 |
Why?
|
G2 Phase | 1 | 2004 | 29 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2004 | 133 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 121 | 0.010 |
Why?
|
Cell Cycle | 1 | 2004 | 326 | 0.010 |
Why?
|
DNA Damage | 1 | 2004 | 352 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2004 | 1198 | 0.010 |
Why?
|